Klinische Wochenschrift

, Volume 63, Issue 8, pp 344–351 | Cite as

The pathophysiology of cholesterol metabolism in man

  • Ch. J. Packard
  • J. Shepherd
Übersichten

Summary

The concentration of low density lipoprotein in human plasma depends on the balance between its rates of synthesis and catabolism. Although both processes appear to be independently regulated they occur side by side in the liver and may be linked via the activity of the high affinity low density lipoprotein receptor on hepatocyte membranes. Dietary changes such as cholesterol feeding or variation in fat content can promote synthesis of the lipoprotein without changing catabolism while other interventions (e.g. sequestrant resin therapy) have the opposite effect. These different responses may be explained on the basis of compartmentalisation of regulatory sterol pools in the liver cell.

Key words

Lipoprotein Receptors Drugs Hormones 

Abbreviations

apo

apolipoprotein

FH

familial hypercholesterolaemia

HDL

high density lipoproteins (d=1.063–1.21 kg/l)

HMG CoA reductase

3-hydroxy-3-methylglutaryl Coenzyme A reductase

IDL

intermediate density lipoproteins (d=1.006–1.019 kg/l)

LDL

low density lipoproteins (d=1.019–1.063 kg/l)

VLDL

very low density lipoproteins (d<1.006 kg/l)

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Dietschy JM (1984) Regulation of cholesterol metabolism in man and in other species. Klin Wochenschr 62:338–345Google Scholar
  2. 2.
    Havel RJ, Goldstein JL, Brown MS (1980) Lipoproteins and lipid transport. In: Bondy PK, Rosenberg LE (eds) Metabolic Control and Disease. WB Saunders, Philadelphia, pp 393–494Google Scholar
  3. 3.
    Kane JP, Hardman DA, Paulus HE (1980) Heterogeneity of apolipoprotein B: Isolation of a new species from human chylomicrons. Proc Natl Acad Sci USA 77:2465–2469Google Scholar
  4. 4.
    Goldstein JL, Brown MS (1983) Familial Hypercholesterolemia. In: Stanbury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown MS (eds) The Metabolic Basis of Inherited Disease. McGraw Hill, New York, pp 672–712Google Scholar
  5. 5.
    Goldstein JL, Brown MS (1977) The low density lipoprotein pathway and its relation to atherosclerosis. Ann Rev Biochem 46:897–930Google Scholar
  6. 6.
    Goldstein JL, Brown MS (1978) Familial hypercholesterolemia: Pathogenesis of a receptor disease. Johns Hopkins Med J 143:8–16Google Scholar
  7. 7.
    Shepherd J, Bicker S, Lorimer AR, Packard CJ (1979) Receptor mediated low density lipoprotein catabolism in man. J Lipid Res 20:999–1006Google Scholar
  8. 8.
    Packard CJ, McKinney L, Carr K, Shepherd J (1983) Cholesterol feeding increases low density lipoprotein synthesis. J Clin Invest 72:45–51Google Scholar
  9. 9.
    Goldstein JL, Brown MS (1977) Atherosclerosis, the low density lipoprotein receptor hypothesis. Metabolism 26:1257–1275Google Scholar
  10. 10.
    Mahley RW, Hui DY, Innerarity TL, Weisgraber KH (1981) Two independent lipoprotein receptors on hepatic membranes of dog, swine and man. J Clin Invest 68:1197–1206Google Scholar
  11. 11.
    Quintao E, Grundy SM, Ahrens EH (1971) Effects of dietary cholesterol on the regulation of total body cholesterol in man. J Lipid Res 12:233–247Google Scholar
  12. 12.
    Nestel P, Tada N, Billington T, Huff M, Fidge N (1982) Changes in very low density lipoproteins with cholesterol loading in man. Metabolism 31:398–405Google Scholar
  13. 13.
    Packard CJ, Shepherd J (1983) Low density lipoprotein receptor pathway in man: Its role in regulating plasma low density lipoprotein levels. Atheroscler Revs 11:29–64Google Scholar
  14. 14.
    Kesaniemi YA, Grundy SM (1984) Turnover of low density lipoproteins during inhibition of cholesterol absorption by neomycin. Atherosclerosis 4:41–48Google Scholar
  15. 15.
    Balasubramaniam S, Mitropolous KA, Myant NB (1973) Evidence for the compartmentalisation of cholesterol in rat liver microsomes. Eur J Biochem 34:77–83Google Scholar
  16. 16.
    Schonfeld G, Patsch W, Rudel LL, Nelson C, Epstein M, Olson RE (1982) Effects of dietary cholesterol and fatty acids on plasma lipoproteins. J Clin Invest 62:1072–1080Google Scholar
  17. 17.
    Shepherd J, Packard CJ, Grundy SM, Yeshurun D, Gotto AM, Taunton OD (1980) Effects of saturated and polyunsaturated fat diets on the chemical composition and metabolism of low density lipoproteins in man. J Lipid Res 21:91–99Google Scholar
  18. 18.
    Shepherd J, Packard CJ, Patsch JR, Gotto AM, Taunton OD (1978) Effects of dietary polyunsaturated and saturated fat on the properties of high density lipoproteins and the metabolism of apolipoprotein AI. J Clin Invest 61:1582–1592Google Scholar
  19. 19.
    Rudel LL, Parks JS (1982) Different kinetic fates of apolipoproteins AI and AII from lymph chylomicra of non human primates. Effect of saturated versus polyunsaturated dietary fat. J Lipid Res 23:410–421Google Scholar
  20. 20.
    Cortese C, Levy Y, Janus ED, Turner PR, Rao SN, Miller NE, Lewis B (1983) Modes of action of lipid lowering diets in man: Studies of apolipoprotein B kinetics in relation to fat consumption and dietary fat composition. Eur J Clin Invest 13:79–85Google Scholar
  21. 21.
    Blum CB, Levy RI, Eisenberg S, Hall M, Goebel RH, Berman M (1977) High density lipoprotein metabolism in man. J Clin Invest 60:795–807Google Scholar
  22. 22.
    Chait A, Bierman EL, Albers JJ (1979) Regulatory role of triiodothyronine in the degradation of low density lipoproteins by cultured human skin fibroblasts. J Clin Endocrinol Metab 48:887–889Google Scholar
  23. 23.
    Thompson GR, Soutar AK, Spengel FA, Jadhav A, Gavigan SJP, Myant NB (1981) Defects of receptor mediated low density lipoprotein catabolism in homozygous familial hypercholesterolemia and hypothyroidismin vivo. Proc Natl Acad Sci USA 78:2591–2595Google Scholar
  24. 24.
    Kovanen P, Brown MS, Goldstein JL (1979) Increased binding of low density lipoprotein to liver membranes from rats treated with 17-ethinyl estradiol. J Biol Chem 254:11367–11373Google Scholar
  25. 25.
    Nikkila EA, Hormilla P (1978) Serum lipids and lipoproteins in insulin treated diabetes. Diabetes 27:1078–1086Google Scholar
  26. 26.
    Chait A, Bierman EL, Albers JJ (1978) Regulatory role of insulin in the degradation of low density lipoproteins by cultured human skin fibroblasts. Biochim Biophys Acta 529:292–299Google Scholar
  27. 27.
    Brown MS, Goldstein JL, Fredrickson DS (1983) Familial Type III hyperlipoproteinemia (Dysbetalipoproteinemia). In: Stanbury JP, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown MS (eds) The metabolic basis of inherited disease. WB Saunders, New York, pp 655–671Google Scholar
  28. 28.
    Weisgraber KH, Innerarity TL, Mahley RW (1982) Abnormal lipoprotein receptor binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site. J Biol Chem 257:2518–2521Google Scholar
  29. 29.
    Packard CJ, Munro A, Lorimer AR, Gotto AM, Shepherd J (1984) Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects. J Clin Invest 74:2178–2192Google Scholar
  30. 30.
    Shepherd J, Packard CJ, Stewart JM, Atmeh RF, Clark RS, Boag DE, Carr K, Lorimer AR, Ballantyne D, Morgan HG, Lawrie TDV (1984) Apolipoprotein A and B (Sf 100–400) metabolism during bezafibrate therapy in hypertriglyceridemic subjects. J Clin Invest 74:2164–2177Google Scholar
  31. 31.
    Soutar AK, Myant NB, Thompson GR (1982) The metabolism of very low density and intermediate density lipoproteins in patients with familial hypercholesterolemia. Atherosclerosis 43:217–231Google Scholar
  32. 32.
    Tolleshaug H, Hobgood KK, Brown MS, Goldstein JL (1983) The LDL receptor locus in familial hypercholesterolemia: Multiple mutations disrupting the transport and processing of the membrane receptor. Cell 32:941–951Google Scholar
  33. 33.
    Russell DW, Schneider WJ, Yamamoto T, Luskey KL, Brown MS, Goldstein JL (1984) Domain map of the LDL receptor: Sequence homology with the epidermal growth factor precursor. Cell 37:577–585Google Scholar
  34. 34.
    Packard CJ, Shepherd J (1982) The hepatobiliary axis and lipoprotein metabolism. J Lipid Res 23:1081–1098Google Scholar
  35. 35.
    Bilheimer DW, Grundy SM, Brown MS, Goldstein JL (1983) Mevinolin and colestipol stimulate receptor mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes. Proc Natl Acad Sci USA 80:4124–4128Google Scholar
  36. 36.
    Starzl TE, Bahnson HT, Hardesty RL, Iwatsuki S, Gartner JC, Bilheimer DW, Shaw BW, Griffith BP, Zitelli BJ, Malatack JJ, Urbach AH (1984) Heart-liver transplantation in a patient with familial hypercholesterolaemia. Lancet i:1382–1383Google Scholar

Copyright information

© Springer-Verlag 1985

Authors and Affiliations

  • Ch. J. Packard
    • 1
  • J. Shepherd
    • 1
  1. 1.Department of BiochemistryRoyal InfirmaryGlasgow

Personalised recommendations